US · Healthcare · Medical Devices
EPS came in at 1.34 against a street estimate of 1.65 — a miss of 18.8%.
Analysts rate Integer Holdings Corp a hold (0 buy, 9 hold, 0 sell out of 9) with an average price target of $127.00.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.75% |
| Amvescap Plc. | 6.61% |
| Vanguard Portfolio Management, LLC | 6.00% |
| Dimensional Fund Advisors, Inc. | 4.79% |
| Nomura Holdings Inc | 4.57% |
| Vanguard Capital Management, LLC | 4.51% |
| State Street Corp | 4.16% |
| Morgan Stanley - Brokerage Accounts | 3.96% |
| Document | Date |
|---|---|
| Quarterly report · Q4 2026 HEADLINE NUMBERS • Third-quarter 2026 sales were $449.661 million, down from $467.691 million in the third quarter of 2025. • Nine-month 2026 sales | 2026-10-29 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter 2026 sales decreased 3.9% to $450 million; organic sales decreased 2.2%. • GAAP operating income fell 50% to $28 mi | 2026-10-29 |
| Shareholder vote results · Q4 2026 MERGER APPROVAL • Integer Holdings Corporation stockholders approved the merger agreement with Armstrong Parent, Inc. and Armstrong Bidco, Inc., affi | 2026-10-21 |
| Company announcement · Q4 2026 HEADLINE NUMBERS • Integer Holdings (NYSE: ITGR) filed an October 14, 2026 Form 8-K updating disclosures related to its proposed acquisition by affil | 2026-10-14 |
| Company announcement · Q4 2026 HEADLINE NUMBERS • On October 2, 2026, Integer Holdings Corporation announced that its 2.125% Convertible Senior Notes due 2028 became convertible du | 2026-10-02 |
| Company announcement · Q3 2026 HEADLINE NUMBERS • Integer Holdings Corporation (NYSE: ITGR) announced on September 30, 2026 that it received early termination of the Hart-Scott-Rod | 2026-09-30 |
| Quarterly report · Q3 2026 INTEGER HOLDINGS CORPORATION - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Sales (6 months): $903.7 million vs. $913.9 million prior year (down 1.1%) • | 2026-08-04 |
| Material agreement · Q3 2026 INTEGER HOLDINGS CORPORATION – FORM 8-K SUMMARY HEADLINE NUMBERS • Merger price: $127 per share in cash for all outstanding common stock • Company t | 2026-08-04 |
Readable in the app.
| Announcement | Date |
|---|---|
| Merger with KKR-backed Armstrong Parent receives HSR early termination Integer Holdings Corporation announced that its previously disclosed merger with KKR-affiliated entities has cleared a major regulatory hurdle. On September 30, 2026, the company received ea | 2026-09-30 |
| Agreement and Plan of Merger with Armstrong Parent and Armstrong Bidco Integer Holdings Corporation filed an 8-K on August 4, 2026, disclosing a merger agreement dated August 2, 2026. The company entered into an Agreement and Plan of Merger with Armstrong Paren | 2026-08-04 |
| Agreed to be acquired by KKR affiliate for $127 per share Integer Holdings Corporation has agreed to be acquired by KKR (Kohlberg Kravis Roberts) for $127 per share, valuing the company at approximately $5.7 billion in enterprise value. The deal wa | 2026-08-03 |
| KKR to acquire all outstanding shares in all-cash transaction Integer Holdings Corporation reported mixed Q2 2026 results with declining sales but stable adjusted earnings. Sales fell 2.6% to $464 million, with organic decline of 1.5%. The company's ma | 2026-08-03 |
| Q1 2026 results in line with outlook; updates full year 2026 guidance ranges Integer Holdings, a medical device company, reported Q1 2026 results that met expectations but revealed concerning trends. Sales grew only 0.5% to $440 million with modest 1.3% organic growt | 2026-04-30 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Integer Holdings Corp — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.